• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群在动脉粥样硬化发生中的代谢作用的新方面。

New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.

机构信息

Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

出版信息

Metabolism. 2015 Apr;64(4):476-81. doi: 10.1016/j.metabol.2015.01.007. Epub 2015 Jan 22.

DOI:10.1016/j.metabol.2015.01.007
PMID:25676802
Abstract

Gut microbiota remains a very interesting, yet largely unexplored ecosystem inside the human organism. The importance of this ecosystem for the physiology and the pathophysiology of the organism is being slowly unraveled. Recent studies reveal a connection between intestinal microbiota and atherosclerosis development. It seems that alterations in the function and composition of this bacterial population lead through complex mechanisms to a high risk for atherosclerosis. Although these mechanisms remain largely unknown, published studies show that microbiota can lead to atherosclerosis either by augmenting known risk factors or via other, more "direct" mechanisms. This review article summarizes the available literature regarding this matter.

摘要

肠道微生物群仍然是人体内部一个非常有趣但在很大程度上尚未被探索的生态系统。这个生态系统对机体的生理学和病理生理学的重要性正在被慢慢揭示。最近的研究揭示了肠道微生物群与动脉粥样硬化发展之间的联系。似乎这种细菌群体的功能和组成的改变通过复杂的机制导致了动脉粥样硬化的高风险。尽管这些机制在很大程度上尚不清楚,但已发表的研究表明,微生物群可以通过增强已知的危险因素或通过其他更“直接”的机制导致动脉粥样硬化。本文综述了关于这一问题的现有文献。

相似文献

1
New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.肠道微生物群在动脉粥样硬化发生中的代谢作用的新方面。
Metabolism. 2015 Apr;64(4):476-81. doi: 10.1016/j.metabol.2015.01.007. Epub 2015 Jan 22.
2
Gut microbiota metabolism of L-carnitine and cardiovascular risk.肉碱的肠道微生物代谢与心血管风险。
Atherosclerosis. 2013 Dec;231(2):456-61. doi: 10.1016/j.atherosclerosis.2013.10.013. Epub 2013 Oct 24.
3
Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.减肥手术后一年,微生物群依赖的促动脉粥样硬化代谢物氧化三甲胺大幅增加。
Metab Syndr Relat Disord. 2016 May;14(4):197-201. doi: 10.1089/met.2015.0120. Epub 2016 Jan 26.
4
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.通过改变左旋肉碱的微生物降解来抑制肠道微生物群依赖的促动脉粥样硬化三甲胺 N-氧化物的产生。
Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7.
5
Gut Microbiota and Atherosclerosis.肠道微生物群与动脉粥样硬化。
Curr Atheroscler Rep. 2017 Aug 25;19(10):39. doi: 10.1007/s11883-017-0675-9.
6
You Are What You Eat: Metabolites of Gut Microbiota Provide Novel Insights into Diagnosis and Development of Chronic Kidney Disease.吃什么成什么:肠道微生物群的代谢产物为慢性肾脏病的诊断和发展提供了新见解。
Transplantation. 2015 Jul;99(7):1306-7. doi: 10.1097/TP.0000000000000793.
7
The role of intestinal microbiota in the pathogenesis of metabolic diseases.肠道微生物群在代谢性疾病发病机制中的作用。
Acta Sci Pol Technol Aliment. 2016 Apr-Jun;15(2):201-211. doi: 10.17306/J.AFS.2016.2.20.
8
The contributory role of gut microbiota in cardiovascular disease.肠道微生物群在心血管疾病中的促成作用。
J Clin Invest. 2014 Oct;124(10):4204-11. doi: 10.1172/JCI72331. Epub 2014 Oct 1.
9
Gut Microbiota, Atherosclerosis, and Therapeutic Targets.肠道微生物群、动脉粥样硬化与治疗靶点
Crit Pathw Cardiol. 2019 Sep;18(3):139-142. doi: 10.1097/HPC.0000000000000187.
10
Intestinal Microbiota Metabolism and Atherosclerosis.肠道微生物群代谢与动脉粥样硬化
Chin Med J (Engl). 2015 Oct 20;128(20):2805-11. doi: 10.4103/0366-6999.167362.

引用本文的文献

1
Association of constipation with all-cause mortality among individuals with type 2 diabetes: A retrospective cohort study.2型糖尿病患者便秘与全因死亡率的关联:一项回顾性队列研究。
J Diabetes Investig. 2025 Mar;16(3):501-509. doi: 10.1111/jdi.14375. Epub 2024 Dec 24.
2
Functional Foods in Preventing Human Blood Platelet Hyperactivity-Mediated Diseases-An Updated Review.功能性食品在预防人类血小板活性过高介导的疾病中的作用——最新综述。
Nutrients. 2024 Oct 30;16(21):3717. doi: 10.3390/nu16213717.
3
Serum immunoglobulin M is associated with the severity of coronary artery disease in adults.
血清免疫球蛋白M与成人冠状动脉疾病的严重程度相关。
PeerJ. 2024 Mar 5;12:e17012. doi: 10.7717/peerj.17012. eCollection 2024.
4
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.肠道微生物群及其代谢途径调节心血管疾病。
Front Microbiol. 2023 Sep 26;14:1272479. doi: 10.3389/fmicb.2023.1272479. eCollection 2023.
5
Allogeneic Adipose-Derived Mesenchymal Stem Cell Transplantation Alleviates Atherosclerotic Plaque by Inhibiting Ox-LDL Uptake, Inflammatory Reaction and Endothelial Damage in Rabbits.异体脂肪来源间充质干细胞移植通过抑制氧化型低密度脂蛋白摄取、炎症反应和内皮损伤减轻兔动脉粥样硬化斑块
Cells. 2023 Jul 26;12(15):1936. doi: 10.3390/cells12151936.
6
A study of the correlation between stroke and gut microbiota over the last 20years: a bibliometric analysis.过去20年中风与肠道微生物群相关性的研究:一项文献计量分析。
Front Microbiol. 2023 Jun 7;14:1191758. doi: 10.3389/fmicb.2023.1191758. eCollection 2023.
7
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy.载有依洛尤单抗的生物脂质体用于高效动脉粥样硬化治疗。
J Nanobiotechnology. 2023 May 19;21(1):158. doi: 10.1186/s12951-023-01904-4.
8
Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure.肠道微生物组的组成是否会影响高血压?涉及血压升高的分子机制。
Int J Mol Sci. 2023 Jan 10;24(2):1377. doi: 10.3390/ijms24021377.
9
Association of Stool Frequency and Consistency with the Risk of All-Cause and Cause-Specific Mortality among U.S. Adults: Results from NHANES 2005-2010.美国成年人粪便频率和稠度与全因及特定病因死亡率风险的关联:2005 - 2010年美国国家健康与营养检查调查结果
Healthcare (Basel). 2022 Dec 22;11(1):29. doi: 10.3390/healthcare11010029.
10
Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model.人脐带间充质干细胞对高脂饮食兔模型主动脉粥样硬化斑块的治疗潜力。
Stem Cell Res Ther. 2021 Jul 15;12(1):407. doi: 10.1186/s13287-021-02490-8.